Skip to main content
letter
. 2020 Aug 16;62(1):e114–e117. doi: 10.1111/ajd.13412

Figure 2.

Figure 2

Original and modelled total PASI scores from screening to Week 12 in each treatment group in model development population (r2 range for IXE [Q2W, Q4W], ETN and placebo groups were 0.945‐0.9982; P <0.0001). n range is from screening to Week 12. Only data from the first 12 weeks of treatment were used to validate the Tele‐PASI model (n range for IXE Q2W: n = 1119‐1169; placebo: n = 746‐792; etanercept: n = 701‐740). Abbreviations: ETN, etanercept; IXE Q2W, 80 mg ixekizumab every 2 weeks; n, number of patients; PASI, Psoriasis Area and Severity Index.